Boehringer Ingelheim Acquires Evax to Expand Equine Health
Ingelheim, Germany, August,11, 2026 Boehringer Ingelheim has acquired Evax AG, a Swiss biotechnology company focused on equine health, expanding...
corporate governance
Advertisement
Philips and Exor Strengthen Long-Term Relationship Agreement
Amsterdam, the Netherlands, August,11, 2026 Royal Philips and Exor N.V. have agreed to update their long-term relationship agreement, reinforcing...
Lupin Earns TIME Recognition for Global Sustainability Leadership
MUMBAI, India, July 6, 2026 Lupin Limited, one of the world’s leading pharmaceutical companies, has been recognized among TIME...
Johnson & Johnson Declares Q1 2026 Dividend, Signals Stability
NEW BRUNSWICK, NEW JERSEY | January 2, 2026 — Johnson & Johnson announced that its Board of Directors has...
BYT Launches NCIB Amid AGM Results to Strengthen Corporate Outlook
Vancouver, British Columbia — December 2, 2025 — BYT Holdings Ltd. announced its plan to initiate a Normal Course...
Advertisements
Protagenic Therapeutics Faces Nasdaq Delisting After Dual Compliance Failures
NEW YORK, NY — November 27, 2025: Protagenic Therapeutics, Inc., a clinical-stage biopharmaceutical company, has announced receipt of a...
Medexus Announces 10% NCIB to Strengthen Shareholder Value
Toronto, Ontario & Chicago, Illinois — November 20, 2025 — Medexus Pharmaceuticals Inc. has announced that the Toronto Stock...
CS Diagnostics Strengthens Financial Structure Through Share Conversion
NEW YORK, November 3, 2025 — CS Interpharm and CS Diagnostics Pharma (CSDX) have announced the completion of a...
Phio Pharmaceuticals Strengthens Governance with New Lead Director
King of Prussia, Pennsylvania – October 31, 2025 — Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biopharmaceutical company developing...
PharmaDrug Restructures Debt to Strengthen Biopharma Pipeline
Toronto, Ontario – October 31, 2025 — PharmaDrug Inc. (CSE: PHRX; OTC Pink: LMLLF), a specialty pharmaceutical company focused...
Advertisement
